McKesson Co. (NYSE:MCK) has received a consensus recommendation of “Hold” from the twenty brokerages that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $175.27.

MCK has been the topic of a number of research analyst reports. Needham & Company LLC set a $179.00 price target on McKesson and gave the company a “buy” rating in a report on Monday, October 16th. ValuEngine upgraded McKesson from a “hold” rating to a “buy” rating in a report on Tuesday, October 31st. Zacks Investment Research upgraded McKesson from a “hold” rating to a “buy” rating and set a $177.00 target price on the stock in a report on Tuesday, December 26th. Deutsche Bank began coverage on McKesson in a report on Monday, December 4th. They set a “buy” rating and a $175.00 target price on the stock. Finally, Robert W. Baird reiterated a “buy” rating and set a $200.00 target price on shares of McKesson in a report on Wednesday, January 17th.

Shares of McKesson (MCK) traded up $2.60 during trading hours on Friday, reaching $172.96. The company had a trading volume of 1,561,200 shares, compared to its average volume of 1,658,593. McKesson has a 52 week low of $133.82 and a 52 week high of $173.88. The stock has a market cap of $35,640.00, a P/E ratio of 8.19, a PEG ratio of 1.74 and a beta of 1.23. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 1.05.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Thursday, October 26th. The company reported $3.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.78 by $0.50. McKesson had a return on equity of 24.87% and a net margin of 2.24%. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.69 billion. During the same quarter in the previous year, the business earned $2.94 EPS. McKesson’s revenue was up 4.2% compared to the same quarter last year. equities research analysts anticipate that McKesson will post 12.26 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Friday, December 1st were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.79%. McKesson’s dividend payout ratio (DPR) is 6.44%.

In related news, Chairman John H. Hammergren sold 65,000 shares of the company’s stock in a transaction that occurred on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total value of $10,400,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.20% of the stock is currently owned by corporate insiders.

Several institutional investors have recently bought and sold shares of the stock. BRYN MAWR TRUST Co bought a new position in McKesson in the 2nd quarter valued at approximately $208,000. Mutual of America Capital Management LLC lifted its position in McKesson by 2.7% in the 2nd quarter. Mutual of America Capital Management LLC now owns 25,743 shares of the company’s stock valued at $4,236,000 after acquiring an additional 672 shares in the last quarter. GSA Capital Partners LLP lifted its position in McKesson by 253.2% in the 2nd quarter. GSA Capital Partners LLP now owns 9,721 shares of the company’s stock valued at $1,599,000 after acquiring an additional 6,969 shares in the last quarter. ETRADE Capital Management LLC bought a new position in McKesson in the 2nd quarter valued at approximately $292,000. Finally, TIAA FSB bought a new position in McKesson in the 2nd quarter valued at approximately $4,731,000. Institutional investors own 87.84% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/mckesson-co-mck-receives-174-85-average-pt-from-analysts/1820265.html.

McKesson Company Profile

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.

Analyst Recommendations for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.